CO [Chinard Bloodrp] UPLOAD:
[]
[SINOCOKING COAL AND COKE CHEMICAL INDUSTRIES UPDATES STATUS OF OPERATIONS AT ITS RECENTLY LEASED 200,000 METRIC TON COKE PRODUCTION FACILITY PINGDINGSHAN, China – May 1, 2013 - SinoCoking Coal and Coke Chemical Industries, Inc. (Nasdaq: SCOK) (the "Company" or "SinoCoking"), SinoCoking’s Chairman and CEO, Mr. Jianhua Lv, noted, “Through operating the Hongfeng facility, we aim to gain and hone the] []
[SINOCOKING COAL AND COKE CHEMICAL INDUSTRIES UPDATES STATUS OF OPERATIONS AT ITS RECENTLY LEASED 200,000 METRIC TON COKE PRODUCTION FACILITY PINGDINGSHAN, China – May 1, 2013 - SinoCoking Coal and Coke Chemical Industries, Inc. (Nasdaq: SCOK) (the "Company" or "SinoCoking"), SinoCoking’s Chairman and CEO, Mr. Jianhua Lv, noted, “Through operating the Hongfeng facility, we aim to gain and hone the] []
[STRICTLY CONFIDENTIAL Execution Version SHARE PURCHASE AGREEMENT Agreement Purchaser Seller Seller Affiliate Parties Party This SHARE PURCHASE AGREEMENT (this Common Stock Company WHEREAS, Seller desires to sell to Purchaser, and Purchaser desires to purchase from Seller, an aggregate of 3,112,920 shares of common stock ( NOW THEREFORE, in consideration of the foregoing and the mutual promises, covenants and agreements] [SCHEDULE 13D [Rule 13d-101] (Amendment No. 5)* CHINA BIOLOGIC PRODUCTS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 16938C106 (CUSIP Number) 18th Floor, Jialong International Building, 19 People's Republic of China (+86) 10-6598-3111 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) April 29, 2013 (Date of Event]
[STRICTLY CONFIDENTIAL Execution Version SHARE PURCHASE AGREEMENT Agreement Purchaser Seller Seller Affiliate Parties Party This SHARE PURCHASE AGREEMENT (this Common Stock Company WHEREAS, Seller desires to sell to Purchaser, and Purchaser desires to purchase from Seller, an aggregate of 3,112,920 shares of common stock ( NOW THEREFORE, in consideration of the foregoing and the mutual promises, covenants and agreements] [SCHEDULE 13D [Rule 13d-101] (Amendment No. 5)* CHINA BIOLOGIC PRODUCTS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 16938C106 (CUSIP Number) 18th Floor, Jialong International Building, 19 People's Republic of China (+86) 10-6598-3111 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) April 29, 2013 (Date of Event]
[Execution Version STRICTLY CONFIDENTIAL SHARE PURCHASE AGREEMENT Agreement Purchaser Seller Seller Affiliate Parties Party This SHARE PURCHASE AGREEMENT (this Common Stock Company WHEREAS, Seller desires to sell to Purchaser, and Purchaser desires to purchase from Seller, an aggregate of 3,112,920 shares of common stock ( NOW THEREFORE, in consideration of the foregoing and the mutual promises, covenants and agreements] [16938C106 CUSIP No. 1. Names of Reporting Persons.]
[Execution Version STRICTLY CONFIDENTIAL SHARE PURCHASE AGREEMENT Agreement Purchaser Seller Seller Affiliate Parties Party This SHARE PURCHASE AGREEMENT (this Common Stock Company WHEREAS, Seller desires to sell to Purchaser, and Purchaser desires to purchase from Seller, an aggregate of 3,112,920 shares of common stock ( NOW THEREFORE, in consideration of the foregoing and the mutual promises, covenants and agreements] [16938C106 CUSIP No. 1. Names of Reporting Persons.]
[CNOOC Limited Announces Proposed Offering of Guaranteed Notes CNOOC Limited (the Company, NYSE: CEO, SEHK: 00883) announced on May 1, 2013 that it intends to offer, subject to market and other conditions, guaranteed notes (the Notes) in four series. The Notes will be issued by CNOOC Finance (2013) Limited, a wholly owned subsidiary of the Company incorporated in the British]
[CNOOC Limited Announces Proposed Offering of Guaranteed Notes CNOOC Limited (the Company, NYSE: CEO, SEHK: 00883) announced on May 1, 2013 that it intends to offer, subject to market and other conditions, guaranteed notes (the Notes) in four series. The Notes will be issued by CNOOC Finance (2013) Limited, a wholly owned subsidiary of the Company incorporated in the British]
[SUBJECT TO COMPLETION, DATED May 1, 2013 Registration No. 333-188261 Registration No. 333-188261-01 PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED May 1, 2013 CNOOC Finance (2013) Limited (incorporated with limited liability in the British Virgin Islands) US$ % Guaranteed Notes due 2016 US$ % Guaranteed Notes due 2018 US$ % Guaranteed Notes due 2023 US$ % Guaranteed Notes due 2043 unconditionally and]